ConductScience.org, home

Paper25246162

Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.

Greenblatt DJ and 6 others. Drugs Aging, 2014. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects. Papers, record 25246162. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25246162

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.
PubMed
Journal
Drugs Aging
PubMed
Year
2014
PubMed
Publication types
Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.58
iCite
Revised in PubMed
2026-06-03
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Greenblatt DJDavid J
2Harmatz JSJerold S
3Singh NNNikhilesh N
4Steinberg FFrank
5Roth TThomas
6Harris SCStephen C
7Kapil RPRam P

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AgingMajor topic
Hypnotics and SedativesMajor topic
PyridinesMajor topic
Administration, Sublingual
Adult
Aged
Area Under Curve
Cross-Over Studies
Female
Health Services for the Aged
Humans
Male
Zolpidem

Source PubMed

Download CSV of topics

References29

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
123923991Zolpidem and driving impairment--identifying persons at risk.N Engl J Med2013https://conductscience.org/library/papers/23923991PubMed
221192134Psychotropic drug prescribing in the United States: extent, costs, and expenditures.J Clin Psychopharmacol2011https://conductscience.org/library/papers/21192134PubMed
317907263Daytime pharmacodynamic and pharmacokinetic evaluation of low-dose sublingual transmucosal zolpidem hemitartrate.Hum Psychopharmacol2008https://conductscience.org/library/papers/17907263PubMed
423853559Middle-of-the-night hypnotic use in a large national health plan.J Clin Sleep Med2013https://conductscience.org/library/papers/23853559PubMed
518374943Nocturnal awakenings and comorbid disorders in the American general population.J Psychiatr Res2008https://conductscience.org/library/papers/18374943PubMed
627128605Sleep-promoting medications: Weighing the hazards of use versus non-use.Clin Pharmacol Drug Dev2014https://conductscience.org/library/papers/27128605PubMed
719484833Evidence-based recommendations for the assessment and management of sleep disorders in older persons.J Am Geriatr Soc2009https://conductscience.org/library/papers/19484833PubMed
823248080Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration.BMJ2012https://conductscience.org/library/papers/23248080PubMed
918788653Low-dose sublingual zolpidem tartrate is associated with dose-related improvement in sleep onset and duration in insomnia characterized by middle-of-the-night (MOTN) awakenings.Sleep2008https://conductscience.org/library/papers/18788653PubMed
1019738366Sleep disorders in the older adult - a mini-review.Gerontology2010https://conductscience.org/library/papers/19738366PubMed
1123372266
Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Sleep2013https://conductscience.org/library/papers/23372266PubMed
1212919178Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.Br J Clin Pharmacol2003https://conductscience.org/library/papers/12919178PubMed
1323541711
Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
Clin Ther2013https://conductscience.org/library/papers/23541711PubMed
1422112177Sublingual zolpidem tartrate lozenge for the treatment of insomnia.Expert Rev Clin Pharmacol2009https://conductscience.org/library/papers/22112177PubMed
1522607251Gender differences in highway driving performance after administration of sleep medication: a review of the literature.Traffic Inj Prev2012https://conductscience.org/library/papers/22607251PubMed
1622424586Zolpidem for insomnia.Expert Opin Pharmacother2012https://conductscience.org/library/papers/22424586PubMed
1710773013Comparative kinetics and response to the benzodiazepine agonists triazolam and zolpidem: evaluation of sex-dependent differences.J Pharmacol Exp Ther2000https://conductscience.org/library/papers/10773013PubMed
1815634031The influence of age and sex on the clearance of cytochrome P450 3A substrates.Clin Pharmacokinet2005https://conductscience.org/library/papers/15634031PubMed
1915536461Age and gender effects on the pharmacokinetics and pharmacodynamics of triazolam, a cytochrome P450 3A substrate.Clin Pharmacol Ther2004https://conductscience.org/library/papers/15536461PubMed
201684924Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part I).Clin Pharmacokinet1991https://conductscience.org/library/papers/1684924PubMed

See all 29 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
41554554Hypnotic doses of fazamorexant induced less impairment on balance and cognition than zolpidem in healthy younger and elderly individuals.Br J Clin Pharmacol2026https://conductscience.org/library/papers/41554554PubMed
38814377Central Nervous System Medications: Pharmacokinetic and Pharmacodynamic Considerations for Older Adults.Drugs Aging2024https://conductscience.org/library/papers/38814377PubMed
34580385Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.Sci Rep2021https://conductscience.org/library/papers/34580385PubMed
27574509Alcohol and Aldehyde Dehydrogenases Contribute to Sex-Related Differences in Clearance of Zolpidem in Rats.Front Pharmacol2016https://conductscience.org/library/papers/27574509PubMed
26414986
Clinical Practice Guideline for the Treatment of Intrinsic Circadian Rhythm Sleep-Wake Disorders: Advanced Sleep-Wake Phase Disorder (ASWPD), Delayed Sleep-Wake Phase Disorder (DSWPD), Non-24-Hour Sleep-Wake Rhythm Disorder (N24SWD), and Irregular Sleep-Wake Rhythm Disorder (ISWRD). An Update for 2015: An American Academy of Sleep Medicine Clinical Practice Guideline.
J Clin Sleep Med2015https://conductscience.org/library/papers/26414986PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25246162

GET https://conductscience.org/api/papers/v1/25246162/references?page=2